The Impact of the Recent AAP Changes in Palivizumab Authorization on RSV-induced Bronchiolitis Severity and Incidence

Italian Journal of Pediatrics - United Kingdom
doi 10.1186/s13052-017-0390-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Palivizumab and RSV Prevention

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2000English

Sustainability in the AAP Bronchiolitis Quality Improvement Project

Journal of Hospital Medicine
Internal MedicineCare PlanningHealth PolicyFundamentalsSkillsLeadershipManagementDiagnosisMedicineAssessment
2017English

Protective Role of Catalase in RSV Bronchiolitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Respiratory Syncytial Virus (RSV) Immune Globulin and Palivizumab for Prevention of RSV Infection

American Journal of Health-System Pharmacy
MedicineHealth PolicyPharmacologyPharmacy
2000English

The Impact of Cold Therapy on the Incidence and Severity of Paclitaxel Induced Peripheral Neuropathy: A Pilot Study

Journal of Solid Tumors
Cancer ResearchOncologyRadiologyNuclear MedicineImaging
2016English

Respiratory Syncytial Virus (RSV) Bronchiolitis: Comparative Study of RSV Groups a and B Infected Children

Revista da Sociedade Brasileira de Medicina Tropical
ParasitologyInfectious DiseasesMicrobiology
1994English

Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Infants With CHD &Premature Infants.

International Journal of Advanced Research
2017English

Monoclonal Antibody Treatment of RSV Bronchiolitis in Young Infants: A Randomized Trial

Pediatrics
Child HealthPediatricsPerinatology
2019English

536 Cat: In High-Risk Infants Hospitalised With Bronchiolitis, Is the Use of Palivizumab (IG) Vaccine Warranted?

Pediatric Research
Child HealthPediatricsPerinatology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy